X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

For more information about The Food and Drug Administration’s (FDA’s) approval for drugs, medical devices and biologics, visit www.fda.gov. The FDA’s new mission statement says that the agency is responsible, inter alia, for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation; for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health. The site offers:

Hot Topics on the site include: BSE (“Mad Cow Disease”), Ephedra, Imported Drugs, Counterterrorism, Bioterrorism Act, Counterfeit Drugs, and Buying Medicines Online. The information about online prescriptions contains tips and warnings for consumers. For example, purchasing online from an illegal Web site puts the purchaser at risk. He or she may receive a contaminated or counterfeit product, the wrong product, an incorrect dose, or no product at all. Additional risks include potentially dangerous drug interactions and other serious health consequences.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

 
Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.

 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.